SRC promotes survival and invasion of lung cancers with epidermal growth factor receptor abnormalities and is a potential candidate for molecular-targeted therapy. [electronic resource]
Producer: 20090918Description: 923-32 p. digitalISSN:- 1557-3125
- Apoptosis -- drug effects
- Carcinoma, Non-Small-Cell Lung -- enzymology
- Cell Line, Tumor
- Cell Movement -- drug effects
- ErbB Receptors -- antagonists & inhibitors
- Gefitinib
- Gene Amplification
- Humans
- Immunohistochemistry
- Lung Neoplasms -- enzymology
- Mutation
- Neoplasm Invasiveness
- Phosphorylation -- drug effects
- Protein Kinase Inhibitors -- pharmacology
- Quinazolines -- pharmacology
- RNA, Small Interfering -- genetics
- Reproducibility of Results
- src-Family Kinases -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.